Device Wound Closure

Monocryl

Payments companies reported to CMS as associated with Monocryl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)

1,224clinicians with associated payments

5companies reporting

By year

2023 $553K

2024 $405K

2025 $310K

Payments reported as associated with Monocryl, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Physician Assistant $447K

Surgical $358K

Adult Reconstructive Orthopaedic Surgery $210K

Neurological Surgery $88K

Surgery $34K

Internal Medicine $26K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Monocryl

These are the largest totals companies reported as associated with Monocryl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Steven Wurzelbacher	Cincinnati, OH	Physician Assistant	$150,236.50
Michael Mont	Baltimore, MD	Adult Reconstructive Orthopaedic Surgery	$99,715.25
Joshua Beardsley	Rock Hill, SC	Surgical	$98,759.36
Jeanine Gargiulo	Alexandria, VA	Surgical	$87,749.93
Michael Wang	Miami, FL	Neurological Surgery	$87,565.00
Gerald Buchert	Bellaire, TX	Surgical	$80,006.13
Sara Holland	Madison, WI	Physician Assistant	$72,294.59
Heather Austin	Salinas, CA	Physician Assistant	$70,874.16
Ryan Nunley	Saint Louis, MO	Adult Reconstructive Orthopaedic Surgery	$55,110.00
Sarah Laub	New Albany, OH	Physician Assistant	$46,794.22

Prescribed Monocryl?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.